Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of the Sialylation of Antibodies Specific to the HCV E2 Envelope Glycoprotein with Hepatic Fibrosis Progression and Antiviral Therapy Efficacy.

Disease markers - 1 Jan 2020

Kurtenkov Oleg, Jakovleva Jelena, Sergejev Boris, Geller Julia

Abstract excerpt

The E2 envelope glycoprotein of the hepatitis C virus (HCV) is a major target of broadly neutralizing antibodies that are closely related to a spontaneous cure of HCV infection. There is still no data about the diversity of E2-specific antibodies (Abs) glycosylation. The aim of this study was to analyze the level and sialylation of E2 IgG Abs, the relation of the respective changes to hepatic fibrosis (F)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Glycosylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Immunoglobulin G

Share to Interferon alpha-2

Share to Liver Cirrhosis

Share to Ribavirin

Share to Viral Envelope Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 32685058
DOI: 10.1155/2020/8881279
PMCID: PMC7333057

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of the Sialylation of Antibodies Specific to the HCV E2 Envelope Glycoprotein with Hepatic Fibrosis Progression and Antiviral Therapy Efficacy.PMID 32685058Read ↗

Blood<i>N</i>-glycomic signature of fibrosis in MASLD shows low levels of global α2,3-sialylationSemantic proximity Read ↗

IgA displays site- and subclass-specific glycoform differences despite equal glycoenzyme expressionSemantic proximity Read ↗

EGFR core fucosylation, induced by enveloped viruses, promotes TRIM40-mediated-RIG-I ubiquitination and suppresses interferon-I antiviral defensesSemantic proximity Read ↗

N-Glycosylation and N-Glycan Processing in HBV Biology and PathogenesisSemantic proximity Read ↗

Fucosylated Glycoproteins as Markers of Liver DiseaseSemantic proximity Read ↗

Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease.Semantic proximity Read ↗

Inhibition of hepatitis C virus 3a genotype entry through Glanthus Nivalis Agglutinin.Semantic proximity Read ↗

Phenotype-related differential alpha-2,6- or alpha-2,3-sialylation of glycoprotein N-glycans in human chondrocytes.Semantic proximity Read ↗

Human Erythrocyte Surface Fucose Expression Increases with Age and HyperglycemiaSemantic proximity Read ↗

Structures of disease-specific serum alpha-fetoprotein isoformsSemantic proximity Read ↗

Structure of pre-S2 N- and O-linked glycans in surface proteins from different genotypes of hepatitis B virus.Semantic proximity Read ↗

Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.